Literature DB >> 22357646

Age-related differences in patterns of increased Bordetella pertussis antibodies.

Harry E Prince1, Jay M Lieberman, James D Cherry.   

Abstract

During the period 2008 to 2010, we identified 11,386 serum samples with increased (positive) levels of antibodies recognizing Bordetella pertussis antigens. We sought to characterize the distribution of positive antibody result patterns in relation to patient age. IgG and IgA antibodies recognizing pertussis toxin (PT) and filamentous hemagglutinin (FHA) were quantified using a multianalyte immunodetection assay. Four mutually exclusive positive result patterns were observed: increased FHA antibodies only, increased PT IgA but not IgG, increased PT IgG but not IgA, and increased PT IgG and IgA. In patients < 21 years old, the predominant pattern was increased PT IgG but not IgA, whereas in patients ≥ 21 years old, it was increased FHA antibodies only. The proportion of positive serum samples exhibiting increased PT IgA but not IgG was < 20% in all age categories but showed a stepwise rise with age. The proportions of positive serum samples exhibiting increased PT IgG and IgA were similar (26 to 32%) in the age categories spanning 11 to 60 years of age but lower in the < 11- and > 60-year-old groups. In 3 of 5 age categories, a significant rise in the proportion of positive serum samples exhibiting increased FHA antibodies only occurred in 2010. Patterns of positive B. pertussis antibody results varied with age. The predominance of increased FHA antibodies only in patients > 20 years old suggests that many adults thought to have B. pertussis infections actually have other infections that induce FHA-reactive antibodies. Similarly, the 2010 rise in the frequency of increased FHA antibodies only in some age groups suggests an increase in non-B. pertussis infections.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22357646      PMCID: PMC3318290          DOI: 10.1128/CVI.05725-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  27 in total

1.  Prolonged afebrile nonproductive cough illnesses in American soldiers in Korea: a serological search for causation.

Authors:  J M Vincent; J D Cherry; W F Nauschuetz; A Lipton; C M Ono; C N Costello; L K Sakaguchi; G Hsue; L A Jackson; R Tachdjian; P A Cotter; J A Gornbein
Journal:  Clin Infect Dis       Date:  2000-03       Impact factor: 9.079

2.  Chlamydia pneumoniae infection in adult patients with persistent cough.

Authors:  Naoyuki Miyashita; Hiroshi Fukano; Koichiro Yoshida; Yoshihito Niki; Toshiharu Matsushima
Journal:  J Med Microbiol       Date:  2003-03       Impact factor: 2.472

3.  Serologic response and antibody-titer decay in adults with pertussis.

Authors:  Ulrich Heininger; James D Cherry; Klemens Stehr
Journal:  Clin Infect Dis       Date:  2004-01-29       Impact factor: 9.079

4.  Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study.

Authors:  Thuan Le; James D Cherry; Swei-Ju Chang; Maria Deloria Knoll; Martin L Lee; Steve Barenkamp; David Bernstein; Robert Edelman; Kathryn M Edwards; David Greenberg; Wendy Keitel; John Treanor; Joel I Ward
Journal:  J Infect Dis       Date:  2004-07-07       Impact factor: 5.226

5.  A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine.

Authors:  K Stehr; J D Cherry; U Heininger; S Schmitt-Grohé; M uberall; S Laussucq; T Eckhardt; M Meyer; R Engelhardt; P Christenson
Journal:  Pediatrics       Date:  1998-01       Impact factor: 7.124

6.  A search for Bordetella pertussis infection in university students.

Authors:  C M Mink; J D Cherry; P Christenson; K Lewis; E Pineda; D Shlian; J A Dawson; D A Blumberg
Journal:  Clin Infect Dis       Date:  1992-02       Impact factor: 9.079

7.  Patterns of Bordetella parapertussis respiratory illnesses: 2008-2010.

Authors:  James D Cherry; Brent L Seaton
Journal:  Clin Infect Dis       Date:  2011-12-07       Impact factor: 9.079

8.  Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents.

Authors:  S L Hodder; J D Cherry; E A Mortimer; A B Ford; J Gornbein; K Papp
Journal:  Clin Infect Dis       Date:  2000-07-24       Impact factor: 9.079

9.  Comparative study of Lederle/Takeda acellular and Lederle whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants in Germany.

Authors:  U Heininger; J D Cherry; P D Christenson; T Eckhardt; U Göering; P Jakob; W Kasper; D Schweingel; S Laussucq; J G Hackell
Journal:  Vaccine       Date:  1994-01       Impact factor: 3.641

10.  Mycoplasma pneumoniae and respiratory virus infections in children with persistent cough in England: a retrospective analysis.

Authors:  Kay Wang; Victoria Chalker; Alison Bermingham; Timothy Harrison; David Mant; Anthony Harnden
Journal:  Pediatr Infect Dis J       Date:  2011-12       Impact factor: 2.129

View more
  9 in total

Review 1.  Immune persistence after pertussis vaccination.

Authors:  Zhiyun Chen; Qiushui He
Journal:  Hum Vaccin Immunother       Date:  2017-01-03       Impact factor: 3.452

2.  Influence of maternal vaccination against diphtheria, tetanus, and pertussis on the avidity of infant antibody responses to a pertussis containing vaccine in Belgium.

Authors:  Raïssa Nadège Caboré; Kirsten Maertens; Alexandre Dobly; Elke Leuridan; Pierre Van Damme; Kris Huygen
Journal:  Virulence       Date:  2017-02-22       Impact factor: 5.882

3.  Estimated incidence of pertussis in people aged <50 years in the United States.

Authors:  Chi-Chang Chen; Catherine Balderston McGuiness; Girishanthy Krishnarajah; Christopher M Blanchette; Yuanyuan Wang; Kainan Sun; Philip O Buck
Journal:  Hum Vaccin Immunother       Date:  2016-05-31       Impact factor: 3.452

4.  Impact of age and vaccination history on long-term serological responses after symptomatic B. pertussis infection, a high dimensional data analysis.

Authors:  Inonge van Twillert; Axel A Bonačić Marinović; Betsy Kuipers; Jacqueline A M van Gaans-van den Brink; Elisabeth A M Sanders; Cécile A C M van Els
Journal:  Sci Rep       Date:  2017-01-16       Impact factor: 4.379

5.  Seroprevalence of IgA and IgM antibodies to Bordetella pertussis in healthy Japanese donors: Assessment for the serological diagnosis of pertussis.

Authors:  Rei Fumimoto; Nao Otsuka; Hajime Kamiya; Tomimasa Sunagawa; Keiko Tanaka-Taya; Kazunari Kamachi; Keigo Shibayama
Journal:  PLoS One       Date:  2019-07-01       Impact factor: 3.240

6.  More than 10 years after introduction of an acellular pertussis vaccine in infancy: a cross-sectional serosurvey of pertussis in the Netherlands.

Authors:  Pauline Versteegen; Guy A M Berbers; Gaby Smits; Elisabeth A M Sanders; Fiona R M van der Klis; Hester E de Melker; Nicoline A T van der Maas
Journal:  Lancet Reg Health Eur       Date:  2021-09-06

7.  The Use of Innovative Two-Component Cluster Analysis and Serodiagnostic Cut-Off Methods to Estimate Prevalence of Pertussis Reinfections.

Authors:  Inonge van Twillert; Axel A Bonačić Marinović; Jacqueline A M van Gaans-van den Brink; Betsy Kuipers; Guy A M Berbers; Nicoline A T van der Maas; Theo J M Verheij; Florens G A Versteegh; Peter F M Teunis; Cécile A C M van Els
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

8.  The estimated incidence of pertussis in people aged 50 years old in the United States, 2006-2010.

Authors:  Cristina Masseria; Girishanthy Krishnarajah
Journal:  BMC Infect Dis       Date:  2015-11-19       Impact factor: 3.090

Review 9.  The Pertussis resurgence: putting together the pieces of the puzzle.

Authors:  Rotem Lapidot; Christopher J Gill
Journal:  Trop Dis Travel Med Vaccines       Date:  2016-12-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.